Childhood ALL and second neoplasms

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Biology & Therapy

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/cbt.6.10.4928PMID 17952026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.

  2006cited by this paper
• Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.

  2006cited by this paper
• Treatment of acute lymphoblastic leukemia.

  2006cited by this paper
• Meningioma transcript profiles reveal deregulated Notch signaling pathway.

  2005cited by this paper
• Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study

  2005cited by this paper
• Epidemiology of intracranial meningioma.

  2005cited by this paper
• The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

  2005cited by this paper
• Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia

  2005cited by this paper
• Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas

  2005cited by this paper
• Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.

  2004cited by this paper
• Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

  2004cited by this paper
• Acute lymphoblastic leukemia.

  2004cited by this paper
• Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.

  2004cited by this paper
• Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland.

  2004cited by this paper
• Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

  2004influential reference
• Functional significance of S6K overexpression in meningioma progression

  2004cited by this paper
• Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

  2004cited by this paper
• Comparative Genomic Hybridization Analysis of Genetic Alterations Associated with Malignant Progression of Meningioma

  2004cited by this paper
• Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia

  2004cited by this paper
• Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

  2004cited by this paper
• Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

  2003cited by this paper
• Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia

  2003cited by this paper
• Results of therapy for acute lymphoblastic leukemia in black and white children.

  2003cited by this paper
• The core-binding factor leukemias: lessons learned from murine models.

  2003cited by this paper
• Gene expression profiling in T-cell acute lymphoblastic leukemia.

  2003cited by this paper
• Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.

  2003cited by this paper
• Role of telomeres and telomerase in the pathogenesis of human cancer.

  2003cited by this paper
• Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.

  2003cited by this paper
• Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

  2003cited by this paper
• Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

  2002cited by this paper
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

  2002cited by this paper
• Core-binding factors in haematopoiesis and leukaemia

  2002cited by this paper
• Allelic Gain and Amplification on the Long Arm of Chromosome 17 in Anaplastic Meningiomas

  2002cited by this paper
• The association between breast carcinoma and meningioma in women

  2002cited by this paper
• MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

  2002cited by this paper
• E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

  2002cited by this paper
• BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

  2002cited by this paper
• Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.

  2002cited by this paper
• The role of E2A-PBX1 in leukemogenesis

  2001cited by this paper
• The Role of the AML1 Transcription Factor in Leukemogenesis

  2001cited by this paper
• Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

  2001cited by this paper
• Childhood acute lymphoblastic leukaemia--current status and future perspectives.

  2001cited by this paper
• Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients

  2001cited by this paper
• Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

  2001cited by this paper
• The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia.

  2001cited by this paper
• Homeobox genes in leukemogenesis.

  2000cited by this paper
• Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

  2000cited by this paper
• Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.

  2000cited by this paper
• Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?

  2000cited by this paper
• Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).

  2000cited by this paper
• Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas

  2000cited by this paper
• Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia.

  2000cited by this paper
• New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.

  2000cited by this paper
• Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.

  2000cited by this paper
• A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients

  2000cited by this paper
• NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas

  1999cited by this paper
• Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

  1999cited by this paper
• Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.

  1999cited by this paper
• The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

  1999cited by this paper
• Regulation of vascular endothelial growth factor secretion in human meningioma cells.

  1999cited by this paper
• Expression of vascular endothelial growth factor in human brain tumors

  1998cited by this paper
• The involvement of calpain-independent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

  1998cited by this paper
• Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.

  1998cited by this paper
• Second malignancies in patients treated for childhood acute lymphoblastic leukemia.

  1998cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin

  1998cited by this paper
• Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

  1997cited by this paper
• Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X

  1997cited by this paper
• Progesterone and estrogen receptors in meningiomas: prognostic considerations.

  1997cited by this paper
• Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus

  1997cited by this paper
• Detection of activated platelet-derived growth factor receptors in human meningioma.

  1997cited by this paper
• Expression and activation of epidermal growth factor receptors in meningiomas.

  1997cited by this paper
• Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas

  1997cited by this paper
• Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas.

  1996cited by this paper
• An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

  1996cited by this paper
• The trends in incidence of primary brain tumors in the population of rochester, minnesota

  1995cited by this paper
• TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

  1995cited by this paper
• Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

  1993cited by this paper
• Epidemiology of intracranial meningioma

  1993cited by this paper
• Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.

  1993cited by this paper
• Expression of insulin‐like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry

  1992cited by this paper
• Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients

  1992influential reference
• Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study.

  1992cited by this paper
• Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia.

  1990cited by this paper
• The clinical significance of blast cell morphology in childhood lymphoblastic leukaemia.

  1986cited by this paper
• Prognostic Importance of Morphology (FAB Classification) in Childhood Acute Lymphoblastic Leukaemia (ALL)

  1981cited by this paper
• Nervous system neoplasms and primary malignancies of other sites

  1975cited by this paper
• [Treatment of acute lymphoblastic leukemia].

  1971cited by this paper

• Presentation and management of spinal meningioma and its association with breast carcinoma—case series and systematic review

  2022cites this paper
• Long-Term Follow-Up of Children Treated for Acute Leukemia Focusing on Development of Malignant and Non-Malignant Neoplasms

  2021cites this paper
• Secondary CNS tumours in children initially treated from ALL according to the treatment protocols of chemotherapy and radiotherapy

  2018cites this paper
• Oxygen, phototherapy, perinatal factors and risk of acute lymphocytic leukemia

  2013cites this paper
• Imaging tumors of the pediatric central nervous system.

  2011cites this paper
• Second neoplasm: 31-year latency after childhood leukemia

  2010cites this paper
• Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report

  2010cites this paper
• Pediatric cancers.

  2008cites this paper